UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-08, Vol.29 (22), p.2965-2971

2011

Volltextzugriff (PDF)

Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

Lung cancer (Amsterdam, Netherlands), 2023-12, Vol.186, p.107418-107418, Article 107418

2023

Volltextzugriff (PDF)

Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden

Clinical cancer research, 2024-02, Vol.30 (4), p.824-835

2024

Volltextzugriff (PDF)

The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial

Journal of thoracic oncology, 2016-06, Vol.11 (6), p.808-818

2016

Volltextzugriff (PDF)

Sarcoidosis lymphoma syndrome - the value of PET-CT in the diagnosis

World journal of surgical oncology, 2013-09, Vol.11 (1), p.235-235, Article 235

2013

Volltextzugriff (PDF)

Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer

Pathology oncology research, 2015-04, Vol.21 (2), p.423-431

2015

Volltextzugriff (PDF)

Supportive care during chemotherapy for lung cancer in daily practice

Magyar onkologia, 2012-09, Vol.56 (3), p.159

2012

Volltextzugriff (PDF)

Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer

BMC pulmonary medicine, 2014-12, Vol.14 (1), p.202-202, Article 202

2014

Volltextzugriff (PDF)

Patterns of erythropoiesis-stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis

Expert opinion on drug safety, 2011-07, Vol.10 (4), p.503-507

2011

Volltextzugriff (PDF)

Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer

Magyar onkologia, 2010-12, Vol.54 (4), p.289

2010

Volltextzugriff (PDF)

Platinum-Based Chemotherapy in Lung Cancer Affects the Expression of Certain Biomarkers Including ERCC1

Pathology oncology research, 2009-09, Vol.15 (3), p.445-450

2009

Volltextzugriff (PDF)

Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy

Magyar onkologia, 2011-06, Vol.55 (2), p.105

2011

Volltextzugriff (PDF)

Effectiveness of erlotinib treatment in advanced KRAS mutation-negative lung adenocarcinoma patients: Results of a multicenter observational cohort study (MOTIVATE)

Lung cancer (Amsterdam, Netherlands), 2014-10, Vol.86 (1), p.54-58

2014

Volltextzugriff (PDF)

Erythropoietic protein supportive treatment in small cell lung cancer

Magyar onkologia, 2008-03, Vol.52 (1), p.43

2008

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Aktive Filter

ThemaLung Neoplasms - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(16)

Sprache

Englisch
(12)
Ungarisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden

The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial

Sarcoidosis lymphoma syndrome - the value of PET-CT in the diagnosis

Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer

Supportive care during chemotherapy for lung cancer in daily practice

Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer

Patterns of erythropoiesis-stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis

Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer

Platinum-Based Chemotherapy in Lung Cancer Affects the Expression of Certain Biomarkers Including ERCC1

Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy

Effectiveness of erlotinib treatment in advanced KRAS mutation-negative lung adenocarcinoma patients: Results of a multicenter observational cohort study (MOTIVATE)

Erythropoietic protein supportive treatment in small cell lung cancer

Aktive Filter

Suchergebnisse filtern